Statistics in Medicine

Table of Contents

Volume 23 Issue 2 (30 January 2004)




  • Author: Richard J. Kryscio, Frederick A. Schmitt
  • Pub Online: Jan 06, 2004
  • DOI: 10.1002/sim.1704 (p 163-167)

Research Articles

Statistical methodology in Alzheimer's disease research II

  • Author:
  • Pub Online: Jan 06, 2004
  • DOI: 10.1002/sim.1705 (p 168-168)

Genetic association studies in Alzheimer's disease research: challenges and opportunities

  • Author: Steven D. Edland, Susan Slager, Matthew Farrer
  • Pub Online: Jan 06, 2004
  • DOI: 10.1002/sim.1706 (p 169-178)

Family‐based association tests for survival and times‐to‐onset analysis

  • Author: Christoph Lange, Deborah Blacker, Nan M. Laird
  • Pub Online: Jan 06, 2004
  • DOI: 10.1002/sim.1707 (p 179-189)

Population‐based studies of AD: message and methods: an epidemiologic view

  • Author: L. J. Launer, D. B. Brock
  • Pub Online: Jan 06, 2004
  • DOI: 10.1002/sim.1708 (p 191-197)

Incidence and mortality of Alzheimer's disease or dementia using an illness‐death model

  • Author: D. Commenges, P. Joly, L. Letenneur, JF. Dartigues
  • Pub Online: Jan 06, 2004
  • DOI: 10.1002/sim.1709 (p 199-210)

A shared random effect parameter approach for longitudinal dementia data with non‐ignorable missing data

  • Author: Sujuan Gao
  • Pub Online: Jan 06, 2004
  • DOI: 10.1002/sim.1710 (p 211-219)

Adjusting for non‐ignorable verification bias in clinical studies for Alzheimer's disease

  • Author: Xiao‐Hua Zhou, Pete Castelluccio
  • Pub Online: Jan 06, 2004
  • DOI: 10.1002/sim.1711 (p 221-230)

Multivariate longitudinal models for complex change processes

  • Author: L. A. Beckett, D. J. Tancredi, R. S. Wilson
  • Pub Online: Jan 06, 2004
  • DOI: 10.1002/sim.1712 (p 231-239)

Test bias in a cognitive test: differential item functioning in the CASI

  • Author: Paul K. Crane, Gerald van Belle, Eric B. Larson
  • Pub Online: Jan 06, 2004
  • DOI: 10.1002/sim.1713 (p 241-256)

Reconsidering the odds ratio as a measure of 2×2 association in a population

  • Author: Helena Chmura Kraemer
  • Pub Online: Jan 06, 2004
  • DOI: 10.1002/sim.1714 (p 257-270)

Selecting pre‐screening items for early intervention trials of dementia—a case study

  • Author: Lang Li, Jeffrey Huang, Sharon Sun, Jianzhao Shen, Frederick W. Unverzagt, Sujuan Gao, Hugh H. Hendrie, Kathleen Hall, Siu L. Hui
  • Pub Online: Jan 06, 2004
  • DOI: 10.1002/sim.1715 (p 271-283)

Designing a large prevention trial: statistical issues

  • Author: Richard J. Kryscio, Marta S. Mendiondo, Frederick A. Schmitt, William R. Markesbery
  • Pub Online: Jan 06, 2004
  • DOI: 10.1002/sim.1716 (p 285-296)

Analytical, practical and regulatory issues in prevention studies

  • Author: Susan S. Ellenberg
  • Pub Online: Jan 06, 2004
  • DOI: 10.1002/sim.1717 (p 297-303)

The evaluation of disease modifying therapies in Alzheimer's disease: a regulatory viewpoint

  • Author: Ranjit B. Mani
  • Pub Online: Jan 06, 2004
  • DOI: 10.1002/sim.1718 (p 305-314)
Page:   1 2 Next

Related Topics

Related Publications

Related Content

Site Footer


This website is provided by John Wiley & Sons Limited, The Atrium, Southern Gate, Chichester, West Sussex PO19 8SQ (Company No: 00641132, VAT No: 376766987)

Published features on are checked for statistical accuracy by a panel from the European Network for Business and Industrial Statistics (ENBIS)   to whom Wiley and express their gratitude. This panel are: Ron Kenett, David Steinberg, Shirley Coleman, Irena Ograjenšek, Fabrizio Ruggeri, Rainer Göb, Philippe Castagliola, Xavier Tort-Martorell, Bart De Ketelaere, Antonio Pievatolo, Martina Vandebroek, Lance Mitchell, Gilbert Saporta, Helmut Waldl and Stelios Psarakis.